SALT LAKE CITY, Jan. 10, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that it will release its financial results for its second fiscal quarter ended December 31, 2010, at the close of market on Thursday, January 27, 2011.
